For citations:

Kashiwagi A., Shoji S., Onozawa S., Kosakai Y., Waratani M., Ito Yu. Reduction in cardiovascular disease events in patients with type 2 diabetes mellitus treated with a sodium–glucose cotransporter 2 inhibitor versus a dipeptidyl peptidase-4 inhibitor: A real-world retrospective administrative database analysis in Japan. Diabetes mellitus. 2023;26(2):157-171. (In Russ.) https://doi.org/10.14341/DM13029